1. |
Cannistraro RJ, Badi M, Eidelman BH, et al. CNS small vessel disease: a clinical review. Neurology, 2019, 92(24): 1146-1156.
|
2. |
Jiménez-Balado J, Riba-Llena I, Abril O, et al. Cognitive impact of cerebral small vessel disease changes in patients with hypertension. Hypertension, 2019, 73(2): 342-349.
|
3. |
Chojdak-Łukasiewicz J, Dziadkowiak E, Zimny A, et al. Cerebral small vessel disease: a review. Adv Clin Exp Med, 2021, 30(3): 349-356.
|
4. |
Fan H, Yang S, Li Y, et al. Assessment of homocysteine as a diagnostic and early prognostic biomarker for patients with acute lacunar infarction. Eur Neurol, 2018, 79(1/2): 54-62.
|
5. |
Mantero V, Scaccabarozzi C, Botto E, et al. Outcome in lacunar stroke: a cohort study. Acta Neurol Scand, 2018, 138(4): 320-326.
|
6. |
Aldriweesh MA, Alluhidan WA, Al Bdah BA, et al. Prevalence and clinical characteristics of lacunar stroke: a hospital-based study. Brain Sci, 2021, 11(11): 1466.
|
7. |
Cao X, Chen P. Changes in serum amyloid A (SAA) and 8-OHdG in patients with senile early cognitive impairment. Med Sci Monit, 2020, 26: e919586.
|
8. |
Asmah RH, Sackey P, Adjei P, et al. Haematological indices and antioxidant enzyme activity in ghanaian stroke patients. Biomed Res Int, 2022, 2022: 1203120.
|
9. |
Schweizer J, Bustamante A, Lapierre-Fétaud V, et al. SAA (serum amyloid A): a novel predictor of stroke-associated infections. Stroke, 2020, 51(12): 3523-3530.
|
10. |
Tao L, ShiChuan W, DeTai Z, et al. Evaluation of lipoprotein-associated phospholipase A2, serum amyloid A, and fibrinogen as diagnostic biomarkers for patients with acute cerebral infarction. J Clin Lab Anal, 2020, 34(3): e23084.
|
11. |
Zhang Y, Feng Y, Zuo J, et al. Elevated serum amyloid A is associated with cognitive impairment in ischemic stroke patients. Front Neurol, 2022, 12: 789204.
|
12. |
Zhang MS, Liang JH, Yang MJ, et al. Low serum superoxide dismutase is associated with a high risk of cognitive impairment after mild acute ischemic stroke. Front Aging Neurosci, 2022, 14: 834114.
|
13. |
Kwan A, Wei J, Dowling NM, et al. Cognitive impairment after lacunar stroke and the risk of recurrent stroke and death. Cerebrovasc Dis, 2021, 50(4): 383-389.
|
14. |
Crosta F, Occhiuzzi U, Passalacqua G, et al. Association between the serum uric acid levels and lacunar infarcts in the elderly. J Mol Neurosci, 2018, 65(3): 385-390.
|
15. |
Su JH, Meng LW, Dong D, et al. Noninvasive model for predicting future ischemic strokes in patients with silent lacunar infarction using radiomics. BMC Med Imaging, 2020, 20(1): 77.
|
16. |
Wu B, Lin S, Hao Z, et al. Proportion, risk factors and outcome of lacunar infarction: a hospital-based study in a Chinese population. Cerebrovasc Dis, 2010, 29(2): 181-187.
|
17. |
Fang XH, Wang WH, Zhang XQ, et al. Incidence and survival of symptomatic lacunar infarction in a Beijing population: a 6-year prospective study. Eur J Neurol, 2012, 19(8): 1114-1120.
|
18. |
Makin SD, Turpin S, Dennis MS, et al. Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes. J Neurol Neurosurg Psychiatry, 2013, 84(8): 893-900.
|
19. |
Arboix A, Martí-Vilalta JL. Lacunar stroke. Expert Rev Neurother, 2009, 9(2): 179-196.
|
20. |
Lau LH, Lew J, Borschmann K, et al. Prevalence of diabetes and its effects on stroke outcomes: a meta-analysis and literature review. J Diabetes Investig, 2019, 10(3): 780-792.
|
21. |
Piernik-Yoder B, Ketchum N. Rehabilitation outcomes of stroke patients with and without diabetes. Arch Phys Med Rehabil, 2013, 94(8): 1508-1512.
|
22. |
Liu J, Rutten-Jacobs L, Liu M, et al. Causal impact of type 2 diabetes mellitus on cerebral small vessel disease: a mendelian randomization analysis. Stroke, 2018, 49(6): 1325-1331.
|
23. |
Cukierman-Yaffe T, McClure LA, Risoli T, et al. The relationship between glucose control and cognitive function in people with diabetes after a lacunar stroke. J Clin Endocrinol Metab, 2021, 106(4): e1521-e1528.
|
24. |
van Sloten TT, Sedaghat S, Carnethon MR, et al. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol, 2020, 8(4): 325-336.
|
25. |
Megherbi SE, Milan C, Minier D, et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke, 2003, 34(3): 688-694.
|
26. |
Blanco M, Castellanos M, Rodríguez-Yáñez M, et al. High blood pressure and inflammation are associated with poor prognosis in lacunar infarctions. Cerebrovasc Dis, 2006, 22(2/3): 123-129.
|
27. |
Yang S, Yuan J, Qin W, et al. Twenty-four-hour ambulatory blood pressure variability is associated with total magnetic resonance imaging burden of cerebral small-vessel disease. Clin Interv Aging, 2018, 13: 1419-1427.
|
28. |
White CL, Pergola PE, Szychowski JM, et al. Blood pressure after recent stroke: baseline findings from the secondary prevention of small subcortical strokes trial. Am J Hypertens, 2013, 26(9): 1114-1122.
|
29. |
Kalani R, Krishnamoorthy S, Deepa D, et al. Apolipoproteins B and A1 in ischemic stroke subtypes. J Stroke Cerebrovasc Dis, 2020, 29(4): 104670.
|
30. |
Yuan S, Tang B, Zheng J, et al. Circulating lipoprotein lipids, apolipoproteins and ischemic stroke. Ann Neurol, 2020, 88(6): 1229-1236.
|
31. |
Rallidis LS, Vikelis M, Panagiotakos DB, et al. Inflammatory markers and in-hospital mortality in acute ischaemic stroke. Atherosclerosis, 2006, 189(1): 193-197.
|
32. |
Tölle M, Huang T, Schuchardt M, et al. High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A. Cardiovasc Res, 2012, 94(1): 154-162.
|
33. |
Song C, Hsu K, Yamen E, et al. Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. Atherosclerosis, 2009, 207(2): 374-383.
|
34. |
Huang HF, Guo F, Cao YZ, et al. Neuroprotection by manganese superoxide dismutase (MnSOD) mimics: antioxidant effect and oxidative stress regulation in acute experimental stroke. CNS Neurosci Ther, 2012, 18(10): 811-818.
|
35. |
Broughton BR, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke, 2009, 40(5): e331-e339.
|
36. |
Ciancarelli I, Di Massimo C, De Amicis D, et al. Uric acid and Cu/Zn superoxide dismutase: potential strategies and biomarkers in functional recovery of post-acute ischemic stroke patients after intensive neurorehabilitation. Curr Neurovasc Res, 2015, 12(2): 120-127.
|